Title : Cytochrome P450 inhibitor\/inducer treatment patterns among patients in the United States with advanced ovarian cancer who were prescribed or were eligible for poly(adenosine diphosphate [ADP]-ribose) polymerase inhibitors in the first-line maintenance setting - Rimel_2024_Gynecol.Oncol.Rep_51_101332